Paper Details

  1. Home
  2. Paper Details

Methamphetamine use and illicit opioid use during buprenorphine treatment.

Author: BlalockKendra, DarntonJames, KimTheresa W, Kratina-HathawayZoë, LerouxBrian G, RadickAndrea C, SametJeffrey H, SaxonAndrew J, TsuiJudith I

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study investigates the association between baseline methamphetamine/amphetamine (MA/A) use and subsequent illicit opioid use among patients with opioid use disorder (OUD) initiating buprenorphine treatment. Methamphetamine use is increasing in the US, and its impact on OUD treatment outcomes is not well understood.
Paper Details　
Original Abstract of the Article :
Although methamphetamine use is rising in the United States, its impacts on patient outcomes among persons undergoing treatment for opioid use disorder (OUD) remain unclear. This study aims to assess the association between baseline methamphetamine/amphetamine (MA/A) use and subsequent illicit opioi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/37811395

データ提供：米国国立医学図書館（NLM）

Methamphetamine and Opioid Use: Navigating the Shifting Sands of Addiction Treatment

The landscape of addiction treatment is a complex and ever-changing desert, with various substances posing unique challenges. This research, published in the journal Drug and Alcohol Dependence, focuses on the impact of methamphetamine use on opioid use disorder (OUD) treatment outcomes, exploring the interplay of these two substances in the desert of addiction.

The study examines the association between baseline methamphetamine/amphetamine (MA/A) use and subsequent illicit opioid use among patients with OUD initiating buprenorphine treatment, a common medication used for OUD management. The researchers aim to understand how methamphetamine use might influence the effectiveness of buprenorphine treatment and the likelihood of relapse to opioid use.

Methamphetamine: A Complicating Factor in Opioid Addiction Treatment

This research underscores the complex interplay of methamphetamine and opioid use in addiction treatment. The study findings suggest that methamphetamine use can impact the effectiveness of buprenorphine treatment and increase the risk of relapse to opioid use.

Navigating the Shifting Sands of Addiction: A Multifaceted Approach

The desert of addiction is a challenging landscape, requiring a multifaceted approach to treatment. This research highlights the importance of understanding the complex interactions between different substances, tailoring treatment strategies to address the unique needs of each individual, and providing ongoing support to help individuals navigate their journey to recovery.

Dr. Camel's Conclusion

The desert of addiction is filled with challenges, and the combination of methamphetamine and opioid use can create a particularly unforgiving landscape. This research helps us understand the complex interplay of these substances and highlights the need for tailored and comprehensive treatment strategies to guide individuals toward recovery.

Date :
  1. Date Completed 2023-11-01
  2. Date Revised 2023-11-13
Further Info :

Pubmed ID

37811395

DOI: Digital Object Identifier

NIHMS1877936

Related Literature

Article Analysis
・Effective treatment of opioid use
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.